Pharmaceuticals, Biotechnology and Life Sciences
RTW Biotech Opportunities Ltd, a London Stock Exchange-listed investment company has made an additional investment in the Series C financing round...
Don't spend too much on your repeated translations.
Cut costs with Vikler Media. Visit: media.vikler.net
RTW Biotech Opportunities Ltd, a London Stock Exchange-listed investment company has made an additional investment in the Series C financing round of Umoja Biopharma ("Umoja"), a clinical-stage biotechnology company aiming to develop in vivo...
CTIM-76 Phase 1 trial focused on CLDN6-positive gynecologic and testicular cancers Trial marks key milestone in driving pipeline progress PHILADELPHIA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or...
Micrima, a Bristol-based health tech company, is urging women to give themselves the gift of prioritising knowledge of their breast density this Christmas. Dense breast tissue is a relatively unknown but common breast cancer risk factor, which additionally makes it...
Brenntag, the global market leader in chemicals and ingredients distribution, held a celebration to mark its 150-year anniversary yesterday in...
Over-65s across the UK are set to benefit from potentially life-changing new treatment options for conditions like cancer and cardiovascular...
RTW Biotech Opportunities Ltd, a London Stock Exchange-listed investment company has made an additional investment in the Series C financing round of Umoja Biopharma (“Umoja”), a clinical-stage biotechnology company aiming to develop in vivo cell therapies that improve the reach, effectiveness, and access of CAR T cell therapies in oncology and autoimmune treatments.
MELBOURNE, Australia and LIÈGE, Belgium, Jan. 17, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the…
PORTLAND, Maine, Jan. 16, 2025 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company…
Christos Richards Christos Richards appointed to Codexis Board of Directors. REDWOOD CITY, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) — Codexis,…
Celadon Pharmaceuticals announced Thursday collaboration with Valeos, a Danish pharmaceutical company, is active and it’s bringing results.
InflaRx N.V. announced Thursday that the European Commission (EC) has granted marketing authorization under exceptional circumstances for GOHIBIC® (vilobelimab) for the treatment of adult patients with SARS-CoV-2-induced acute respiratory distress syndrome
Santhera Pharmaceuticals said Thursday that Idorsia Pharmaceuticals has entered into a royalty monetization agreement with the R-Bridge Healthcare Fund in…
VANCOUVER, British Columbia, Jan. 15, 2025 (GLOBE NEWSWIRE) — Biologic Pharmamedical is proud to announce the launch of its groundbreaking…
Ad hoc announcement pursuant to Art. 53 LR Presentation to take place on January 15, 2025, at 15:00 PST /…
BOSTON, Jan. 15, 2025 (GLOBE NEWSWIRE) — Radiance Biopharma, Inc. a biotechnology company developing next generation Antibody Drug Conjugates (“ADCs”)…
